Nectar Lifesciences Ltd.
NECLIFE Share PricePharmaceuticals & Drugs
₹20.94
3.1 (17.2%)
As on December 4, 2025
Exchange Scrips: BSE532649NSENECLIFEISININE023H01027
Market Cap ₹ 468 Cr
P/E Ratio -4.13
Dividend Yield N/A
Performance
Market performance
Open20.6
High21.21
Volumes5,31,79,172
Prev20.94
Low19.72
As on2025-12-04
Historical performance
1 Year High44.41
3 Year High56.5
5 Year High56.5
1 Year Low13.05
3 Year Low13.05
5 Year Low13.05
Fundamentals
Company Valuation
Market Cap (₹Cr)
468
Face Value (₹)
1
P/E Ratio
-4.13
Dividend Yield
N/A
Investment Returns
1 Year
-38.8%
3 Years
-1.2%
5 Years
5.2%
10 Years
-63.3%
Technicals
| Indicators | Value | Signal |
|---|---|---|
| 5-DMA | 18.34 | Bullish |
| 10-DMA | 16.5 | Bullish |
| 20-DMA | 15.51 | Bullish |
| 50-DMA | 14.79 | Bullish |
| 100-DMA | 15.31 | Bullish |
| 200-DMA | 19.72 | Bullish |
Shareholding Pattern
| Field | Sep-2025 | Jun-2025 | Mar-2025 | Dec-2024 | Sep-2024 |
|---|---|---|---|---|---|
| Promoters | 3 | 3 | 3 | 3 | 2 |
| Foreign Investors | --- | --- | --- | --- | --- |
| Domestic Investors | 3 | 3 | 3 | 3 | 2 |
| Public Investors | 76467 | 71974 | 69238 | 69479 | 66738 |
| Government | 1 | 1 | 1 | 1 | 1 |
Financials
Below figures are in Rs. Crores
Balance Sheet
Below figures are in Rs. Crores
Cash Flow
Below figures are in Rs. Crores
0%
Negative
Neutral
Positive
- The stock has a PE ratio of -4.13.
- 3Y Stock Price CAGR of the stock is -3.0.
- The stock has a beta of 1.1.
- In the last financial year, the company had an EBITDA of ₹-221 Million.
- The company generated revenue of ₹16700 Million in the previous financial year.
Nectar Lifesciences Ltd.
20.943.1 (17.2%)
₹
Investment Amount: ₹ 1000000
Current Value: ₹ 617699.1
No. of Shares: 29499 (Approx)
Performance:-38.2%
P/L: ₹-382300.9
Top Gainers
Peer Comparison
Get Your Portfolio Reviewed
